ROMEFEN 1% ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
ROMEFEN 1% ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Not authorised
- KETOPROFEN
Product identification
Medicine name:
ROMEFEN 1% ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
- KETOPROFEN
Target species:
-
Dog
-
Cat
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
KETOPROFEN1.00/gram(s)100.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Not applicableno withdrawal period
-
-
Cat
-
Not applicableno withdrawal period
-
-
-
Intramuscular use
-
Dog
-
Not applicableno withdrawal period
-
-
Cat
-
Not applicableno withdrawal period
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AE03
Legal status of supply:
-
Medicinal product subject to medical prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Ceva Hellas LLC
Marketing authorisation date:
Manufacturing sites for batch release:
- Merial
- Ceva Sante Animale
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 56330/11-08-2010/K-0088601
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
